IRIS UniCatt

Bria, Pietro
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.376
NA - Nord America 4.422
AS - Asia 1.772
SA - Sud America 170
AF - Africa 33
OC - Oceania 23
Continente sconosciuto - Info sul continente non disponibili 7
Totale 11.803
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.368
DE - Germania 2.093
IT - Italia 754
CN - Cina 732
SE - Svezia 720
SG - Singapore 631
UA - Ucraina 598
FR - Francia 362
GB - Regno Unito 238
IE - Irlanda 200
BR - Brasile 151
FI - Finlandia 133
ID - Indonesia 120
RU - Federazione Russa 106
IN - India 95
TR - Turchia 48
CA - Canada 33
NL - Olanda 32
BE - Belgio 26
PL - Polonia 26
AU - Australia 22
JP - Giappone 22
CI - Costa d'Avorio 20
IR - Iran 18
VN - Vietnam 17
ES - Italia 16
KR - Corea 15
MX - Messico 14
CH - Svizzera 13
HK - Hong Kong 12
AT - Austria 7
EG - Egitto 7
LT - Lituania 7
TW - Taiwan 7
AZ - Azerbaigian 6
IL - Israele 6
AR - Argentina 5
BG - Bulgaria 5
BY - Bielorussia 5
CZ - Repubblica Ceca 5
NO - Norvegia 5
PE - Perù 5
RO - Romania 5
UZ - Uzbekistan 5
CL - Cile 4
HU - Ungheria 4
PH - Filippine 4
TH - Thailandia 4
A1 - Anonimo 3
BD - Bangladesh 3
EC - Ecuador 3
KG - Kirghizistan 3
LA - Repubblica Popolare Democratica del Laos 3
PA - Panama 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
AM - Armenia 2
EU - Europa 2
GR - Grecia 2
HR - Croazia 2
IQ - Iraq 2
JM - Giamaica 2
JO - Giordania 2
LK - Sri Lanka 2
LV - Lettonia 2
MC - Monaco 2
MY - Malesia 2
PK - Pakistan 2
PS - Palestinian Territory 2
RS - Serbia 2
ZA - Sudafrica 2
AE - Emirati Arabi Uniti 1
CO - Colombia 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
IS - Islanda 1
KZ - Kazakistan 1
LB - Libano 1
LU - Lussemburgo 1
MA - Marocco 1
MD - Moldavia 1
MM - Myanmar 1
NZ - Nuova Zelanda 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
TN - Tunisia 1
UY - Uruguay 1
Totale 11.803
Salva come PNG Salva come JPEG
Città #
Chandler 861
Singapore 363
Ashburn 336
Jacksonville 327
San Mateo 245
Dublin 196
Nanjing 182
Milan 168
Wilmington 157
Nürnberg 124
Dearborn 120
Woodbridge 119
Jakarta 117
Bremen 106
Rome 95
Houston 90
Redwood City 90
New York 88
Ann Arbor 77
Nanchang 77
Boston 76
Seattle 70
Lawrence 68
Moscow 65
Beijing 53
University Park 53
Princeton 48
Marseille 47
Norwalk 45
Mountain View 44
Munich 42
Lancaster 40
Los Angeles 37
Fairfield 36
Hebei 33
Cattolica 31
Guangzhou 30
Kunming 30
Shenyang 28
Shanghai 27
Cambridge 26
Tianjin 26
Fremont 25
Hangzhou 25
Izmir 25
Paris 24
Changsha 22
Falls Church 22
Kraków 22
Boardman 21
Abidjan 20
Andover 20
Düsseldorf 20
Brussels 19
Dallas 19
Philadelphia 18
Helsinki 17
Menlo Park 17
Jiaxing 16
Columbus 15
Hanoi 15
Hefei 14
Pune 14
Saint-Ouen-l'Aumone 13
Bologna 12
Detroit 12
Portsmouth 12
São Paulo 12
Augusta 11
Atlanta 10
Bragança 10
Frankfurt am Main 10
Kish 10
Lanzhou 10
Leawood 10
Simi Valley 10
Hong Kong 9
Guidonia 8
Lauterbourg 8
Bari 7
Edinburgh 7
Florence 7
London 7
Ankara 6
Baku 6
Changchun 6
Chicago 6
Indiana 6
Jinan 6
Acton 5
Alzate Brianza 5
Brisbane 5
Busto Arsizio 5
Como 5
Council Bluffs 5
Evanston 5
Kocaeli 5
Modena 5
Nola 5
Oslo 5
Totale 5.589
Salva come PNG Salva come JPEG
Nome #
Pregabalin versus naltrexone in alcohol dependence: a randomised, double-blind, comparison trial 215
Plasma cortisol levels and resilience in depressed patients 210
Programma di trattamento integrato in regime di day hospital per pazienti depressi “difficili” da trattare. 207
Behavioural addictions in bipolar disorder patients: Role of impulsivity and personality dimensions 206
Bipolar Disorder Questionnaire for the Assessment of Learning: a New Instrument for Studying Information Acquisition in Psychoeducational programs. 182
Alterazioni delle risposte immuno-infiammatorie nei pazienti affetti da disturbo depressivo maggiore (Immune-inflammatory response changes in patients with major depressive disorder) 181
Neuroendocrinologia dei disturbi dell umore 177
Pregabalin, tiapride and lorazepam in alcohol withdrawal syndrome: a multi-centre, randomized, single-blind comparison trial. 165
Dopamine transporter availability and psychomotor retardation in major depression 164
Plasma magnesium level and psychomotor retardation in major depressed patients 155
Bipolar disorder: "pure" versus mixed depression over a 1-year follow-up. 154
[Diagnosis of deficit and attention/hyperactivity disorders (ADHD) in patients with bipolar or unipolar depression: an experimental study] 150
Problematic mobile phone use in adolescence: A cross-sectional study 146
Predicting treatment outcome in difficult-to-treat depressed patients 145
Augmentation of drug treatment with bright light therapy in patients with difficult-to-treat depression: acute and long term observation 145
Sexual Behavior in Women with Bipolar Disorder 141
A day treatment programme on mood disorders: One-year activity outcomes 139
Role of Substance Abuse Comorbidity and Personality on the Outcome of Depression in Bipolar Disorder: Harm Avoidance Influences Medium-Term Treatment Outcome. 136
Non-Epileptic Seizures (NES) are predicted by depressive and dissociative symptoms 135
Striatal dopamine transporter (DAT) availability and affective symptoms in movement disorders: a 123I-FP-CIT SPECT study. 134
[Diagnosis of deficit and attention/hyperactivity disorders (ADHD) in patients with bipolar or unipolar depression: an experimental study]. 131
Internet addiction: hours spent online, behaviors and psychological symptoms 130
An observational study evaluating comorbidity between bipolar disorder and personality disorders 126
Plasma magnesium levels and treatment outcome in depressed patients 126
Bipolar disorder: "pure" versus mixed depression over a 1-year follow-up 122
Correlations Between Striatal Dopamine Transporter (DAT) Availability and Psychiatric Symptoms in Movement Disorders: A 123I-FP-CIT SPECT Study. 122
Alcohol protracted withdrawal syndrome: the role of anhedonia 121
Modulation of motor cortex neuronal networks by rTMS: comparison of local and remote effects of six different protocols of stimulation 120
Changing of dopamine transporter binding in depressed patients with anhedonia during treatment 119
Factors associated with the course of symptoms in bipolar disorder during a 1-year follow-up: depression vs. sub-threshold mixed state 119
Plasma magnesium levels and treatment outcome in depressed patients 117
Anhedonia and Cortisol Levels in Major Depression. 114
Behavioural addictions in adolescents and young adults: results from a prevalence study. 113
Treatment of prurigo nodularis with pregabalin. 112
Polysomnographic Findings in a Cohort of Chronic Insomnia Patients with Benzodiazepines Abuse 112
Il trattamento della schizofrenia 111
Clinical features, response to treatment and functional outcome of bipolar disorder patients with and without co-occurring substance use disorder: 1-year follow-up 111
Changes of Dopamine Transporter Availability in Depressed Patients with and without Anhedonia: A 123I-N-ω-Fluoropropyl-Carbomethoxy-3β-(4-Iodophenyl)tropane SPECT Study 111
Cognitive markers of psychotic unipolar depression: A meta-analytic study 111
Role of substance abuse comorbidity and personality on the outcome of depression in bipolar disorder: harm avoidance influences medium-term treatment outcome 110
Psicopatologia nell’epilessia e nella pseudoepilessia: risultati preliminari nella nostra esperienza 109
Pregabalin in outpatient detoxification of subjects with mild-to-moderate alcohol withdrawal syndrome. 108
Predictive value of magnesium levels in depressed patients. 107
Affective temperaments and psychopathological dimensions of personality in bipolar and cyclothymic patients 106
Affective temperament and attachment in adulthood in patients with Bipolar Disorder and Cyclothymia 106
The assessment of post-detoxification anhedonia: influence of clinical and psychosocial variables 104
Augmentation of light therapy in difficult-to-treat depressed patients: an open-label trial in both unipolar and bipolar patients 103
Treatment of prurigo nodularis with pregabalin 102
Striatal dopamine transporter density in anhedonic depressed patients before and after pharmachological treatment 102
Affective temperaments and psychopathological dimensions of personality in Bipolar Disorder 101
Bipolar disorder: "pure" versus mixed depression over a 1-year follow-up 101
Somatic symptoms and high-sensitive C-reactive protein in major depression 100
Clinical correlates of difficult-to-treat depression: Exploring an integrated day-care model of treatment 100
Depression and suicide in epilepsy: Fact or artefact? 99
Duloxetine for premenstrual dysphoric disorder: a pilot study 98
Hyperactivation of inflammatory response in depressed patients with psychomotor retardation 98
Inflammatory response and psychopathological dimensions in major depression 98
SNRI effective treatment does not restore changes of immune and inflammatory parameters in depressed patients 96
Major depressive disorder and dopamine transporter density: investigation by 123I-FP-CIT SPET 95
Plasma dehydroepiandrosterone sulphate (DHEAS) and cortisol in patients with mood disorders 94
Facial emotion recognition deficit in Amnestic Mild Cognitive Impairment and Alzheimer Disease 93
What is the effect of selective serotonin reuptake inhibitors on temperament and character in patients with fibromyalgia? 92
Cocaine use disorders and serum magnesium profile 92
La gestione della crisi suicidaria: dall'emergenza clinica alla riabilitazione del paziente 92
Oxcarbazepine in bipolar disorder: a critical review of the literature 91
Ansia, depressione ed epilessia del lobo temporale 89
Ginkgo biloba and donepezil: a comparison in the treatment of Alzheimer's dementia in a randomized placebo-controlled double-blind study. 89
Antidepressant treatment restores brain-derived neurotrophic factor serum levels and ameliorates motor function in Parkinson disease patients 89
Oxcarbazepine improves mood in patients with epilepsy. 88
Reduced serum concentrations of nerve growth factor, but not brain-derived neurotrophic factor, in chronic cannabis abusers 87
Plasma levels of n-3 fatty acids in bipolar patients: Deficit restricted to DHA 86
Evidenze preliminari sulle modifiche del transporter della dopamina in pazienti depressi con rallentamento psicomotorio 86
Reply to Dr Corrao and colleagues. 85
Oxcarbazepine improves mood in patients with epilepsy 85
Mood, hormones and quality of life. 85
Enhanced BDNF serum levels in patients with severe pathological gambling 85
Omega-3 fatty acids and antioxidants in neurological and psychiatric diseases: an overview. 85
Venlafaxine: Successful treatment in impulsive disorders 84
Omega-3 fatty acids and antioxidants in neurological and psychiatric diseases: an overview 83
Behavioural addictions in adolescents and young adults: results from a prevalence study 83
Sleep Disturbances and Depression: a review 82
Cocaine addiction: from habits to stereotypical-repetitive behaviors and punding 82
Omega-3 fatty acids and antioxidants in neurological and psychiatric diseases: An overview. 82
Enhanced BDNF serum levels in patients with severe pathological gambling 81
Reply to Dr Korczyn. 80
To be or not to be a bipolar disorder patient: problems with diagnosis. 80
Effects of psychostimulants on neurotrophins implications for psychostimulant-induced neurotoxicity. 79
Cognitive markers of psychotic unipolar depression: A meta-analytic study 79
Chronic ketamine use increases serum levels of brain-derived neurotrophic factor. 78
Neuroendocrinology of mood disorders. 74
Effect of aripiprazole on self-reported anhedonia in bipolar depressed patients 74
Bipolar disorder and epilepsy: a bidirectional relation? Neurobiological underpinnings, current hypotheses, and future research directions 72
Poprawa nastroju u chorych na padaczke leczonych okskarbazepina 72
Analisi antropofenomenologica di un'esperienza in un'istituzione manicomiale del meridione 71
DAT binding and psychopathological features in depressed patients. 71
Primary cerebral blood flow deficiency and Alzheimer's disease: shadows and lights. 71
Ecstasy (MDMA)-addicted subjects show increased serum levels of brain-derived neurotrophic factor, independently from a rise of drug-induced psychotic symptoms 71
Il self-help nelle condizioni depressive: analisi dell esperienza di un gruppo di mutuo-aiuto per pazienti depressi in remissione parziale. 70
Functional neuroimaging: points of intersection between biology and psychotherapy. 70
Paliperidone for treatment of obsessive compulsive resistant symptoms in schizophrenia: a case report. 69
Totale 10.929
Salva come PNG Salva come JPEG
Categoria #
all - tutte 45.267
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.267
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020327 0 0 0 0 0 0 0 0 0 0 179 148
2020/20211.260 54 123 29 132 181 67 231 16 137 92 178 20
2021/20221.102 109 135 19 61 40 26 34 193 40 70 169 206
2022/20232.407 297 362 160 409 196 273 121 161 297 22 74 35
2023/20241.003 48 303 23 44 37 112 42 34 35 51 154 120
2024/20251.567 120 108 159 117 208 90 49 149 351 189 27 0
Totale 11.862